Genmab — Januar 2024

[Sukkeralf]

Alligator Bio har succes med deres CD40 monoclonale antistof Mitazalimab, så lad os håbe Genmab kan toppe den:

[Sukkeralf]

Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience

Top-line readout demonstrates Objective Response Rate of 40.4%, meeting primary endpoint and confirming the benefit of mitazalimab in combin ...

(alligatorbioscience.se)

[nohope]

Skal kun stige yderligere 120 % for at jeg går i nul...

[nohope]

-Efter den er steget 280 % på 3 mdr...

[E_L]

Genmab price target raised by $1 at H.C. Wainwright to$50, maintains buy

[w]

insane

[E_L]

too low...?

[gentogen]

Most likely...

[Plimsoller]

That would actually be a very high premium for a takeover right now

[E_L]

and at the current price, many shareholders would go for it... Many years ago Jan already said that, to prevent the risk of a takeover, the best he could do was to try to keep the share price as high as possible; he has got some work to do atm

[Bulder]

Og alt imens sætter Novo ny ATH. Gynger og karusseller - og rutchebane. Et helt Tivoli.

[Plimsoller]

Agree E L

[Raun]

Så er vi tilbage i samme cyklus.... Faldende kurs under høj omsætning.... - Forstår nada?

[w]

..og
larmende tavshed fra ledelsen ovenpå voldgiften

[w]

ingen tør vel gå ind inden regnskab

[E_L]

they are not allowed to talk right now @w .

[Plimsoller]

w Her er definitionen på stilleperioden. Jeg kunne ikke finde den på dansk. https://www.investopedia.com/terms/q/quietperiod.asp

[Bulder]

Berlingske aktieskole fra 2010: Fra Københavns Fondsbørs' side er der ikke nogen regel om sådanne stilleperioder, og det er derfor op til selskaberne selv, om de ønsker at have sådan en tavs periode og i givet fald, hvor længe den skal vare.

[Bulder]

Om det stadig er sådan ved jeg ikke.

[Bulder]

Genmab: Observe quiet periods two weeks before issuing financial reports with no broad discussions with investors and financial analysts. https://ir.genmab.com/